BR9711499A - Uso de prote¡nas como agentes contra doen-as auto-imunes - Google Patents

Uso de prote¡nas como agentes contra doen-as auto-imunes

Info

Publication number
BR9711499A
BR9711499A BR9711499A BR9711499A BR9711499A BR 9711499 A BR9711499 A BR 9711499A BR 9711499 A BR9711499 A BR 9711499A BR 9711499 A BR9711499 A BR 9711499A BR 9711499 A BR9711499 A BR 9711499A
Authority
BR
Brazil
Prior art keywords
proteins
autoimmune diseases
agents against
against autoimmune
agents
Prior art date
Application number
BR9711499A
Other languages
English (en)
Inventor
Alberto Bartorelli
Alberto E Panerai
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961919 external-priority patent/IT1284553B1/it
Priority claimed from ITMI961921 external-priority patent/IT1284555B1/it
Priority claimed from ITMI961920 external-priority patent/IT1284554B1/it
Priority claimed from ITMI961922 external-priority patent/IT1284556B1/it
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of BR9711499A publication Critical patent/BR9711499A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9711499A 1996-09-18 1997-09-17 Uso de prote¡nas como agentes contra doen-as auto-imunes BR9711499A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI961919 IT1284553B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiartritici
ITMI961921 IT1284555B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antidiabetici
ITMI961920 IT1284554B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiaterosclerotici
ITMI961922 IT1284556B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti contro la sclerosi multipla
PCT/EP1997/005079 WO1998011909A1 (en) 1996-09-18 1997-09-17 Use of proteins as agents against autoimmune diseases

Publications (1)

Publication Number Publication Date
BR9711499A true BR9711499A (pt) 1999-08-24

Family

ID=27453037

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711499A BR9711499A (pt) 1996-09-18 1997-09-17 Uso de prote¡nas como agentes contra doen-as auto-imunes

Country Status (22)

Country Link
US (2) US6468536B1 (pt)
EP (1) EP0928197B1 (pt)
JP (1) JP2001501925A (pt)
KR (1) KR20000036207A (pt)
CN (1) CN1151838C (pt)
AR (1) AR009952A1 (pt)
AT (1) ATE233569T1 (pt)
AU (1) AU723669B2 (pt)
BR (1) BR9711499A (pt)
CA (1) CA2266346A1 (pt)
CZ (1) CZ293926B6 (pt)
DE (1) DE69719525T2 (pt)
DK (1) DK0928197T3 (pt)
ES (1) ES2192669T3 (pt)
IL (1) IL129024A0 (pt)
NO (1) NO991175D0 (pt)
NZ (1) NZ334714A (pt)
PL (1) PL188746B1 (pt)
PT (1) PT928197E (pt)
RU (1) RU2196606C2 (pt)
TR (1) TR199900596T2 (pt)
WO (1) WO1998011909A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
WO2001093888A2 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
US20070275890A1 (en) * 2004-01-16 2007-11-29 Johnson Barbara J Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) * 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
IT1244879B (it) 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2688227A1 (fr) * 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale

Also Published As

Publication number Publication date
DE69719525D1 (de) 2003-04-10
CZ293926B6 (cs) 2004-08-18
CA2266346A1 (en) 1998-03-26
AU723669B2 (en) 2000-08-31
EP0928197B1 (en) 2003-03-05
US20030108558A1 (en) 2003-06-12
IL129024A0 (en) 2000-02-17
NO991175L (no) 1999-03-10
ES2192669T3 (es) 2003-10-16
PL332282A1 (en) 1999-08-30
JP2001501925A (ja) 2001-02-13
AR009952A1 (es) 2000-05-17
PT928197E (pt) 2003-06-30
RU2196606C2 (ru) 2003-01-20
WO1998011909A1 (en) 1998-03-26
EP0928197A1 (en) 1999-07-14
CZ91599A3 (cs) 1999-08-11
NZ334714A (en) 2000-08-25
DE69719525T2 (de) 2003-10-02
US6468536B1 (en) 2002-10-22
KR20000036207A (ko) 2000-06-26
AU4774797A (en) 1998-04-14
PL188746B1 (pl) 2005-04-29
CN1230892A (zh) 1999-10-06
TR199900596T2 (xx) 1999-06-21
ATE233569T1 (de) 2003-03-15
NO991175D0 (no) 1999-03-10
CN1151838C (zh) 2004-06-02
DK0928197T3 (da) 2003-06-23

Similar Documents

Publication Publication Date Title
PT888359E (pt) Derivados de pirimidin-4-ona como pesticida
BR9805893A (pt) Prote¡na com a atividade de fosfolipase
BR9600006B1 (pt) proteìnas de corpo oleoso como veìculos de proteìnas de elevado valor.
PA8459901A1 (es) Derivados de resorcinol
DK0906086T3 (da) Hudvasksammensætning
BR9708894A (pt) Derivados de acilmercapto-triazolila e seu uso como microbicidas
ID17437A (id) Metoda dan komposisi untuk membuat kulit terang
BR9709107A (pt) Derivados de tiocianato-triazolila e seu uso como microbicidas
PT900225E (pt) Alquil-4-silil-fenois e esteres destes como agentes antiateroscleroticos
BR9709258A (pt) Derivados de sulfonil-mercaptotriazolila e seu uso como microbicidas
BR9711499A (pt) Uso de prote¡nas como agentes contra doen-as auto-imunes
BR9710648A (pt) S¡ntese de indolilmaleimidas
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
ID16978A (id) Zat pelindung kulit
BR9711789A (pt) Uso de prote nas como agentes anti-retrovirais
PT1066284E (pt) Derivados de benzo [c] quinolizina e sua utilizacao como inibidores de 5-alfa-redutases
BR9710711A (pt) Prepara-Æo de 3-aril-5-haloalquil-pirazÄis substitu¡dos tendo atividade herbicida
BR9706562A (pt) Comutador de fibra birefringente otimizada
FR2766658B1 (fr) Lame de gyro-broyeur
HUP9904268A3 (en) Use of proteins as agents against autoimmune diseases
SI0928197T1 (en) Use of proteins as agents against autoimmune diseases
FR2754257B1 (fr) Preparation de caprolactame
ZA978363B (en) Use of proteins as agents against autoimmune diseases.
PT9393T (pt) Peca de mobiliario polivalente
IT1286059B1 (it) Uso di derivati dello yohimbano come agenti antimetastatici

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1882 DE 30/01/2007.